Filing Details

Accession Number:
0001209191-11-038875
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-07-08 15:20:49
Reporting Period:
2011-07-06
Filing Date:
2011-07-08
Accepted Time:
2011-07-08 15:20:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
59478 Lilly Eli & Co LLY Pharmaceutical Preparations (2834) 350470950
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1401222 M Frank Deane Lilly Corporate Center
Indianapolis IN 46285
President, Mfg. Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-07-06 5,000 $37.20 12,124 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,446 Indirect 401(k)
Footnotes
  1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2011.